Sankar D Navaneethan

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Electronic health records: a new tool to combat chronic kidney disease?
    Sankar D Navaneethan
    Department of Neprology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Clin Nephrol 79:175-83. 2013
  2. ncbi Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006
    S D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Obes (Lond) 36:1585-90. 2012
  3. ncbi Obesity, anthropometric measures and chronic kidney disease complications
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Nephrol 36:219-27. 2012
  4. ncbi Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    Nephrol Dial Transplant 27:3228-34. 2012
  5. ncbi Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology, Hypertension, Glickman Urological and Kidney Institute, and Cleveland Clinic Lerner College of Medicine of CWRU, Cleveland, OH 44195, USA
    Clin J Am Soc Nephrol 6:2395-402. 2011
  6. ncbi Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland, OH 44195, USA
    Am J Kidney Dis 58:536-43. 2011
  7. ncbi Treatment options for proliferative lupus nephritis: an update of clinical trial evidence
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Drugs 68:2095-104. 2008
  8. ncbi Development and validation of an electronic health record-based chronic kidney disease registry
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, 9500 Euclid Avenue, Q7, Cleveland Clinic, Cleveland, OH 44195, USA
    Clin J Am Soc Nephrol 6:40-9. 2011
  9. ncbi Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients
    S D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44122, USA
    Clin Nephrol 73:260-7. 2010
  10. ncbi Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Q7, Cleveland, OH 44195, USA
    Obes Surg 20:308-15. 2010

Detail Information

Publications30

  1. ncbi Electronic health records: a new tool to combat chronic kidney disease?
    Sankar D Navaneethan
    Department of Neprology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Clin Nephrol 79:175-83. 2013
    ..Thus, future studies should explore the optimal methods of using EHRs to improve CKD care and research at the individual patient level, health system and population levels...
  2. ncbi Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006
    S D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Obes (Lond) 36:1585-90. 2012
    ..We aimed to examine: (a) lifestyle and behavioral factors, (b) factors related to pursuing weight loss and (c) weight loss modalities pursued by CKD and non-CKD individuals who are overweight and obese...
  3. ncbi Obesity, anthropometric measures and chronic kidney disease complications
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Nephrol 36:219-27. 2012
    ..We examined the associations of BMI and WC with various CKD complications...
  4. ncbi Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    Nephrol Dial Transplant 27:3228-34. 2012
    ..The associations between serum triglyceride and all-cause mortality among patients with chronic kidney disease (CKD) are unclear...
  5. ncbi Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology, Hypertension, Glickman Urological and Kidney Institute, and Cleveland Clinic Lerner College of Medicine of CWRU, Cleveland, OH 44195, USA
    Clin J Am Soc Nephrol 6:2395-402. 2011
    ..We studied the associations of both low and high serum bicarbonate levels with all-cause mortality among stage 3 and 4 chronic kidney disease (CKD) patients...
  6. ncbi Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland, OH 44195, USA
    Am J Kidney Dis 58:536-43. 2011
    ..Low 25-hydroxyvitamin D (25[OH]D) levels are common in patients with non-dialysis-dependent chronic kidney disease (CKD). The associations between low 25(OH)D levels and mortality in non-dialysis-dependent patients with CKD are unclear...
  7. ncbi Treatment options for proliferative lupus nephritis: an update of clinical trial evidence
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Drugs 68:2095-104. 2008
    ..Ongoing clinical trials will provide further evidence...
  8. ncbi Development and validation of an electronic health record-based chronic kidney disease registry
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, 9500 Euclid Avenue, Q7, Cleveland Clinic, Cleveland, OH 44195, USA
    Clin J Am Soc Nephrol 6:40-9. 2011
    ..We developed an electronic health record (EHR)-based CKD registry at the Cleveland Clinic and validated comorbid conditions...
  9. ncbi Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients
    S D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44122, USA
    Clin Nephrol 73:260-7. 2010
    ..We sought to assess factors influencing PCPs referral patterns in the general population and in geriatric patients, and compared their perceptions to the referral patterns...
  10. ncbi Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Q7, Cleveland, OH 44195, USA
    Obes Surg 20:308-15. 2010
    ..In this pilot study, we determined the effect of weight loss induced by different types of bariatric surgery on albuminuria in severely obese type 2 diabetic (T2DM) subjects...
  11. ncbi Bariatric surgery and progression of chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Surg Obes Relat Dis 5:662-5. 2009
    ..Obesity is an independent predictor for the development and progression of chronic kidney disease (CKD). The effect of weight reduction on the progression of kidney disease in patients with pre-existing CKD is unclear...
  12. ncbi Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin J Am Soc Nephrol 4:542-51. 2009
    ..We evaluated the benefits and harms of adding selective and nonselective AA in CKD patients already on RAS...
  13. ncbi Anti-neutrophil cytoplasmic antibody associated crescentic IgA nephropathy in hematopoietic stem cell transplantation
    S D Navaneethan
    Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland OH 44195, USA
    Clin Nephrol 71:59-62. 2009
    ..The etiology of IgA nephropathy developing after hematopoietic stem cell transplantation is unclear and larger registry-based studies are needed to further explore this condition...
  14. ncbi Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Kidney Dis 53:617-27. 2009
    ..Optimal hydration measures to prevent contrast-induced nephropathy are controversial...
  15. ncbi Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Q7, Cleveland, OH 44122, USA
    Am J Kidney Dis 54:619-37. 2009
    ..Phosphate binders are widely used to control serum phosphorus levels in patients with chronic kidney disease (CKD). We analyzed the effects of phosphate binders on biochemical and patient-level end points in patients with CKD...
  16. ncbi Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin J Am Soc Nephrol 4:1565-74. 2009
    ..We conducted a systematic review to assess the benefits of intentional weight loss in patients with non-dialysis-dependent CKD and glomerular hyperfiltration...
  17. ncbi Metabolic syndrome and mild to moderate chronic kidney disease among minorities
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Semin Nephrol 30:51-8. 2010
    ..We present an integrated pathophysiologic viewpoint that incorporates insights from basic science, socioeconomic inquiry, and clinical studies into a framework for clinical practice and investigation...
  18. ncbi Implications of the CKD-EPI GFR estimation equation in clinical practice
    Jesse D Schold
    Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA
    Clin J Am Soc Nephrol 6:497-504. 2011
    ..CKD-EPI demonstrated superior performance compared with the existing MDRD equation but has not been applied to a healthcare system...
  19. ncbi Metabolic syndrome and kidney disease: a systematic review and meta-analysis
    George Thomas
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Clin J Am Soc Nephrol 6:2364-73. 2011
    ..Risk estimates for eGFR <60 ml/min per 1.73 m(2) were extracted from individual studies and pooled using a random effects model. The results for proteinuria outcomes were not pooled because of the small number of studies...
  20. ncbi 2009 influenza A infection and acute kidney injury: incidence, risk factors, and complications
    Sevag G Demirjian
    Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Am J Nephrol 34:1-8. 2011
    ..Respiratory complications and renal failure have been the leading causes for hospitalization and critical illness. We describe the risk factors and complications of acute kidney injury (AKI) in patients with influenza A...
  21. ncbi Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials
    Praveen Kandula
    Department of Nephrology, Indiana University, Indianapolis, Indiana, USA
    Clin J Am Soc Nephrol 6:50-62. 2011
    ..The benefits and harms of vitamin D supplementation (ergocalciferol or cholecalciferol) were assessed in patients with nondialysis-dependent CKD, dialysis-dependent CKD, and renal transplant recipients...
  22. ncbi Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    Am J Kidney Dis 56:670-85. 2010
    ..Sexual dysfunction is an under-recognized problem in men and women with chronic kidney disease (CKD). The prevalence, correlates, and predictors of this condition in patients with CKD have not been evaluated comprehensively...
  23. ncbi Glomerular filtration rate slopes have significantly improved among renal transplants in the United States
    Titte R Srinivas
    Department of Nephrology and Hypertension, Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Transplantation 90:1499-505. 2010
    ..In recent years, the use of higher risk donor organs and steroid avoidance regimens with potential increased acute rejection risk have increased. We hypothesized that these patterns adversely affect changes in posttransplant renal function...
  24. ncbi Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Curr Opin Nephrol Hypertens 20:146-52. 2011
    ..Dyslipidemia is a well established cardiovascular risk factor. We summarize key aspects of available evidence relating to beneficial effects of statins in nondialysis-dependent CKD, dialysis-dependent CKD and renal transplant recipients...
  25. ncbi Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA, 44195
    Cochrane Database Syst Rev 2:CD006023. 2011
    ..Phosphate binders are widely used to lower serum phosphorus levels in people with chronic kidney disease (CKD) but their impact in CKD remains controversial...
  26. ncbi How to design a randomized controlled trial
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Nephrology (Carlton) 15:732-9. 2010
    ..In this article, the key steps that are required to design a randomized controlled trial are summarized...
  27. ncbi Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH, USA
    Nephrol Dial Transplant 24:1260-6. 2009
    ..It is unclear whether the presence of kidney disease modifies the associations of uric acid with cardiovascular events and death...
  28. ncbi Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis
    Mirela Dobre
    Department of Medicine, Huron Hospital A Cleveland Clinic Hospital, Cleveland, OH, USA
    Int Urol Nephrol 43:175-84. 2011
    ..Hepatorenal syndrome (HRS) is a common complication in patients with cirrhosis or fulminant liver failure. We systematically reviewed the benefits and harms of using terlipressin, a novel vasoconstricting agent in patients with HRS...
  29. ncbi Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial
    Catherine Sullivan
    Center for Reducing Health Disparities, Department of Medicine, Case Western Reserve University, Cleveland, OH 44109, USA
    Clin J Am Soc Nephrol 7:1639-45. 2012
    ..This study sought to determine the effect of navigators on completion of steps...
  30. ncbi Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up
    Helen M Heneghan
    Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Surg Obes Relat Dis 9:7-14. 2013
    ..We hypothesized that improving diabetes control may have positive effects on end-organ complications of this disease, such as diabetic nephropathy (DN)...